Tej Pavan, More Akash, Kalbande Avanti, Nair Nancy
Clinical Embryology, Datta Meghe Medical College, Datta Meghe Institute of Higher Education and Research, Nagpur, IND.
Clinical Embryology, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Cureus. 2024 Sep 2;16(9):e68449. doi: 10.7759/cureus.68449. eCollection 2024 Sep.
Recent advancements in assisted reproductive technology (ART) have enabled couples to achieve pregnancy, who were previously unable to conceive. However, recurrent implantation failure (RIF) remains a significant challenge. This case study exhibits the effective use of hysteroscopic-guided platelet-rich plasma (PRP) instillation in the treatment of a female patient aged 33 who was nulliparous and diagnosed with RIF and a thin endometrium, which resulted in primary infertility. The couple had a history of 10 years of infertility and had previously undergone ART procedures, including intrauterine insemination (IUI) and intracytoplasmic sperm injection (ICSI), which failed. The female partner was diagnosed with a thin endometrium (<7 mm) and underwent hysteroscopy, revealing no other significant intrauterine pathologies. Following hormonal treatment and ovum pick-up, hysteroscopic PRP was administered, resulting in improved endometrial thickness (ET) and successful embryo implantation, as evidenced by a positive serum β-hCG level of 1470 mIU/mL. This case demonstrates the hysteroscopic injection of PRP's potential for increasing endometrial receptivity and enhancing ART outcomes in women with RIF due to thin endometrium, making it a promising alternative to conventional therapies.
辅助生殖技术(ART)的最新进展使以前无法受孕的夫妇能够成功怀孕。然而,反复植入失败(RIF)仍然是一个重大挑战。本病例研究展示了宫腔镜引导下富血小板血浆(PRP)灌注在治疗一名33岁未生育女性患者中的有效应用,该患者被诊断为RIF且子宫内膜薄,导致原发性不孕。这对夫妇有10年的不孕病史,此前接受过包括宫内人工授精(IUI)和卵胞浆内单精子注射(ICSI)在内的ART程序,但均失败。女性伴侣被诊断为子宫内膜薄(<7 mm),并接受了宫腔镜检查,未发现其他明显的宫内病变。在激素治疗和取卵后,进行了宫腔镜下PRP治疗,子宫内膜厚度(ET)得到改善,胚胎成功植入,血清β-hCG水平为1470 mIU/mL,呈阳性。本病例证明了宫腔镜注射PRP在提高因子宫内膜薄而导致RIF的女性子宫内膜容受性和改善ART结局方面的潜力,使其成为传统疗法的一个有前景的替代方案。